Deteksi Gen Litik BRLF1 Epstein-Barr Virus pada Penderita Karsinoma Nasofaring
Abstrak
Kata Kunci
Teks Lengkap:
PDFReferensi
Ariwibowo, H., 2013. Faktor Risiko Karsinoma Nasofaring. CDK-204, 40(5), pp. 348-251.
Barnes, L., Eveson J. W., Reichart P. & Sidransky D., 2005. World Health Organization Classification of Tumours.Pathology and Genetics of Head and Neck Tumours. Lyon: IARC Press.
Bhende, P. M., Seaman W. T., Delecluse H. J. & Kenney, S. C., 2004. The EBV Switch Protein Z, Preferentially Binds and Activates the Methylated Viral Genom. Nat Genet, 36(10), pp. 1999-2004.
Cacais, A. O. G., 2008. Immunological Consequences of Epstein-Barr Virus Replication. Dissertation. Stockholm, Sweden: Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet.
Chang, E. T. & Adami H. O., 2006.The Enigmatic Epidemiology of Nasoparhyngeal Carcinoma. Cancer Epidemiol Biomarkers Prev, 15, pp. 1765-1777.
Chang, Y., Chang S. S., Lee H. H., Doong S. L., Takada K. & Tsai C. H., 2004. Inhibition of the Epstein-Barr Virus Lytic Cycle by Zta-targeted RNA Interference. J Gen Virol, 85, pp. 1371-1379.
Cho, W. C., 2007. Nasopharyngeal Carcinoma: Molecular Discovery and Progress. Mol Cancer, 6(1), pp. 43-56.
Cottrill C. P. & Nutting C. M., 2003.Tumors at the Nasopharynx. London: Martin Dunitz.
Fachiroh, J., Schouten T. & Hariwiyanto B., 2004. Molecular Diversity of Epstein-Barr Virus IgG and IgA Antibody Responses in Nasopharyngeal Carcinoma: A Comparison of Indonesian, Chinese and Europen Subject. The J of Infectious Diseases, 190(1), pp. 53-62.
Fles, R., Wilderman M. A., Sulistiono B., Haryana S. M. & Tan I. B., 2010.Knowledge of General Practioners about Nasopharyngeal Cancer at Puskesmas in Yogyakarta, Indonesia. BMC Medical Education, 10(81), pp. 1-6.
Gautama, E. E., Hariwiyanto, B., Rianto, B. U. D. & Christanto, A., 2001. Gangguan Indra Pengecap dan Penghidu Pasca-terapi Karsinoma Nasofaring. CDK 187, 38(6), pp. 437-437.
Haryanto, A., & Sofia M., 2012. Isolasi dan Amplifikasi Gen Penyandi Domain C-Terminus Latent Membrane Protein (LMP-I) Epstein-barr Virus (EBV) dari Penderita Karsinoma Nasofaring (KNF). J Sain Vet, 18(2), pp. 1-7.
Hsiao, J. R., Yin T. J. & Sen T. T., 2002. Detection of Cell Free Epstein-Barr Virus DNA in Sera from Patients with Nasopharyngeal Carcinoma. Cancer, 94(3), pp. 723-729.
Hsu W. L., Chen J. Y.& Chien Y. C., 2009. Independent Effect of EBV and Cigarette Smoking on Nasopharyngeal Carcinoma: a 20-Year Follow-Up Study on 9,622 Males without Family History in Taiwan. Cancer Epidemiol Biomarkers Prev, 18(1), pp. 1218-1226.
Jemal, A., Bray F., Center C. C., Ferlay J., Ward E.& Forman D., 2011. Global Cancer Statistics.Ca Cancer J Clin, 61, pp. 69-90.
Kenway N., Leung S. F., Johson P.J. & Woo J., 2004. Nutritional Consequences of Radiotherapy in Nasopharynx Cancer Patients.J of Nutrition and Cancer, 2(1), pp. 156-161.
Lo Y. M. D., Chan L. Y. S., Lo C. K. W., Leung S. F., Zhang J. & Chan A. T. C., 1999. Quantitative Analysis of Cell-Free Epstein-Barr Virus DNA in Plasma Patients with Nasopharyngeal Carcinoma. Cancer Res, 59(1), pp. 1188-1191.
Lutan R. & Zachreini I., 1999. Immunohistochemical Corelation between Nasopharyngeal Carcinoma and Epstein Barr Virus. Asean Otorhinolaryngology-Head and Neck Surgery J, 3(3): pp. 257-259.
Munir, D., Ramsi L., Mangain H., & Fauziah H., 2007.Ekspresi Protein p53 Mutan pada Karsinoma Nasofaring. MKN, 40(3), pp. 163-172.
Mutirangura A., Pornthanakasem W., Theamboonlers A., Sriuranpong V., Lertsanguansinchi P. & Yenrudi S., 1998. Epstein-Barr Virus DNA in Serum of Patients with Nasopharyngeal Carcinoma. Clin Cancer Res, 4(1), pp. 665-669.
Neel, H. B., Pearson G. R. & Taylor W. F., 1984. Antibodies to Epstein-Barr Virus in Patient with Nasopharyngeal Carcinoma and Comparison Groups. Ann Otol Rhinol Laryngol, 93(1), pp.447-482.
Roezin, A., 1999. Berbagai Faktor Penyebab dan Predisposisi Karsinoma Nasofaring. Maj Kedokt Indon, 49(3), pp. 85-88.
Sambrook, J. & Russel D.W., 1989. Molecular Cloning: A Laboratory Manual. New York: Cold-Spring Harbor Laboratory Press.
Savitri, E & Sofia M. H., 2012.Profil Viral Load Ebstein-Barr Virus dan Titer Antibodi Ig A (VCA-P18+ EBNA-1) pada Karsinoma Nasofaring di Makassar dan Yogyakarta. J Indon Med Assoc, 62(5), pp. 174-177.
Shotelersuk K., Khorprasert C., Sakdikul S., Pornthanakasem W., Voravud N. & Mutirangura A., 2000. Epstein-Barr virus DNA in Serum/Plasma as a Tumor Marker for Nasopharyngeal Carcinoma. Clin Cancer Res, 6(1), pp. 1046-1051.
Soepardi, E. A., Iskandar N., Bashiruddin J., Restuti R. D., 2007. Buku Ajar Ilmu Kesehatan : Telinga Hidung Tenggorok Kepala dan Leher. Edisi ke 6. Jakarta: Balai Penerbit FKUI.
Steven, S. J. C., Verkuijlen S. A. W. M., Hariwiyanto B., Harijadi, Paramita D. K., Fachiroh J., Marlinda A., Tan I. B., Haryana S. M. & Middeldorp J. M., 2006. Noninvasive Diganosis of Nasopharyngeal Carcinoma: Nasopharyngeal Brushing Reveal High Epstein-Barr Virus (EBV) DNA Load and Carcinoma-Specific Viral BARF1 mRNA. Int J Cancer, 119, pp. 608-614.
Stevens, C. R. & Rassekh C., 1998. Nasopharyngeal Carcinoma. New York: Department of Otolaryngology.
Surzycki, S., 2000.Basic Techniques in Molecular Biology. Berlin: Springer-Verlag.
Syafaruddin & Tri J. S., 2011.Optimasi Teknik Isolasi dan Purifikasi DNA yang Efisien dan Efektif pada Kemiri Sunan (Reutalis trisperma (Blanco) Airy Shaw). J Littri, 17(1), pp. 11-17.
Tselis, A. C. & Hal B. Jenson, 2006.Epstein-Barr Virus. New York: Taylor & Francis.
Wahyono, D.J., Musa, Z., Lisnawati, Suryandar, D.A., Hermani, B., Soeharso. P. Host-pathogen study : The relative expression of mRNA BRLF1 Epstein-Barr virus : a potensial use for biomarker of tumor progresivity & polymorphisms of TCRBC andTCRGC2 penjamu genes related to genetic susceptibility on nasopharyngeal carcinoma. BMC Proceeding 2016 : 7th Biannual International Symposium on Nasopharyngeal Carcinoma 2015, Yogyakarta, Indonesia.
Welsh, K. I. and Bunce, M., 1999. Molecular TTyping for the MHC with PCR-SSP. Immunogenetics, 1(1), pp. 156–176
Wong, Thian-Sze, Dora Lai-Wan Kwong, Jonathan Shun-Tong Sham, William Ignace Wei, Yok-Lam Kwong, & Anthony Po-Wing Yuen, 2004. Quantitative Plasma Hypermethylated DNA Markers of Undifferentiated Nasopharyngeal Carcinoma. Clinical Cancer Res, 10(1), pp. 2401-2406.
Article Reads
Total: 10449 Abstrak: 1549 PDF: 2137Article Metrics
Metrics powered by PLOS ALM
Refbacks
- Saat ini tidak ada refbacks.
Laman ini dikelola oleh:
Bio Publisher
The Faculty of Biology Publishing
Laman ini dikelola oleh:
Penerbitan Fakultas Biologi
Universitas Jenderal Soedirman
Jalan dr. Suparno 63 Grendeng
Purwokerto 53122
Telepon: +62-281-625865
Email: biologi@unsoed.ac.id
Laman ini menggunakan:
OJS | Open Journal System
Software pengelolaan jurnal ilmiah online. Versi yang digunakan adalah 2.4.8.0.
Metadata artikel terdaftar di:
Crossref
Agen resmi internasional pendaftaran Digital Object Identifier (DOI)
Artikel jurnal ini terindeks: